246 related articles for article (PubMed ID: 15655069)
1. Mutagenicity testing with transgenic mice. Part I: Comparison with the mouse bone marrow micronucleus test.
Wahnschaffe U; Bitsch A; Kielhorn J; Mangelsdorf I
J Carcinog; 2005 Jan; 4(1):3. PubMed ID: 15655069
[TBL] [Abstract][Full Text] [Related]
2. Mutagenicity testing with transgenic mice. Part II: Comparison with the mouse spot test.
Wahnschaffe U; Bitsch A; Kielhorn J; Mangelsdorf I
J Carcinog; 2005 Jan; 4(1):4. PubMed ID: 15676065
[TBL] [Abstract][Full Text] [Related]
3. Tissue-specific in vivo genetic toxicity of nine polycyclic aromatic hydrocarbons assessed using the Muta™Mouse transgenic rodent assay.
Long AS; Lemieux CL; Arlt VM; White PA
Toxicol Appl Pharmacol; 2016 Jan; 290():31-42. PubMed ID: 26603514
[TBL] [Abstract][Full Text] [Related]
4. Radiation-induced point mutations, deletions and micronuclei in lacI transgenic mice.
Winegar RA; Lutze LH; Hamer JD; O'Loughlin KG; Mirsalis JC
Mutat Res; 1994 Jun; 307(2):479-87. PubMed ID: 7514721
[TBL] [Abstract][Full Text] [Related]
5. The concomitant detection of gene mutation and micronucleus induction by mitomycin C in vivo using lacZ transgenic mice.
Suzuki T; Hayashi M; Sofuni T; Myhr BC
Mutat Res; 1993 Feb; 285(2):219-24. PubMed ID: 7678894
[TBL] [Abstract][Full Text] [Related]
6. The performance of short-term tests in identifying potential germ cell mutagens: a qualitative and quantitative analysis.
Waters MD; Stack HF; Jackson MA; Bridges BA; Adler ID
Mutat Res; 1994 Dec; 341(2):109-31. PubMed ID: 7527489
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous measurement of benzo[a]pyrene-induced Pig-a and lacZ mutations, micronuclei and DNA adducts in Muta™ Mouse.
Lemieux CL; Douglas GR; Gingerich J; Phonethepswath S; Torous DK; Dertinger SD; Phillips DH; Arlt VM; White PA
Environ Mol Mutagen; 2011 Dec; 52(9):756-65. PubMed ID: 21976233
[TBL] [Abstract][Full Text] [Related]
8. Initial experiences and future directions for transgenic mouse mutation assays.
Suzuki T; Hayashi M; Sofuni T
Mutat Res; 1994 Jun; 307(2):489-94. PubMed ID: 7514722
[TBL] [Abstract][Full Text] [Related]
9. The lacI transgenic mouse mutagenicity assay: quantitative evaluation in comparison to tests for carcinogenicity and cytogenetic damage in vivo.
Shephard SE; Lutz WK; Schlatter C
Mutat Res; 1994 Apr; 306(2):119-28. PubMed ID: 7512210
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of Muta™Mouse λgt10-lacZ transgene: evidence for in vivo rearrangements.
Shwed PS; Crosthwait J; Douglas GR; Seligy VL
Mutagenesis; 2010 Nov; 25(6):609-16. PubMed ID: 20724577
[TBL] [Abstract][Full Text] [Related]
11. N-Nitrosodimethylamine investigations in Muta™Mouse define point-of-departure values and demonstrate less-than-additive somatic mutant frequency accumulations.
Lynch AM; Howe J; Hildebrand D; Harvey JS; Burman M; Harte DSG; Chen L; Kmett C; Shi W; McHugh CF; Patel KK; Junnotula V; Kenny J; Haworth R; Wills JW
Mutagenesis; 2024 Mar; 39(2):96-118. PubMed ID: 38183622
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mouse mutation assay systems can play an important role in regulatory mutagenicity testing in vivo for the detection of site-of-contact mutagens.
Dean SW; Brooks TM; Burlinson B; Mirsalis J; Myhr B; Recio L; Thybaud V
Mutagenesis; 1999 Jan; 14(1):141-51. PubMed ID: 10474836
[TBL] [Abstract][Full Text] [Related]
13. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
14. Genotoxicity of o-aminoazotoluene (AAT) determined by the Ames test, the in vitro chromosomal aberration test, and the transgenic mouse gene mutation assay.
Ohsawa K; Hirano N; Sugiura M; Nakagawa S; Kimura M
Mutat Res; 2000 Nov; 471(1-2):113-26. PubMed ID: 11080667
[TBL] [Abstract][Full Text] [Related]
15. Quantitative dose-response analysis of ethyl methanesulfonate genotoxicity in adult gpt-delta transgenic mice.
Cao X; Mittelstaedt RA; Pearce MG; Allen BC; Soeteman-Hernández LG; Johnson GE; Bigger CA; Heflich RH
Environ Mol Mutagen; 2014 Jun; 55(5):385-99. PubMed ID: 24535894
[TBL] [Abstract][Full Text] [Related]
16. Mutagenic properties of dimethylaniline isomers in mice as evaluated by comet, micronucleus and transgenic mutation assays.
Kohara A; Matsumoto M; Hirose A; Hayashi M; Honma M; Suzuki T
Genes Environ; 2018; 40():18. PubMed ID: 30151062
[TBL] [Abstract][Full Text] [Related]
17. The in vivo gut micronucleus test detects clastogens and aneugens given by gavage.
Vanhauwaert A; Vanparys P; Kirsch-Volders M
Mutagenesis; 2001 Jan; 16(1):39-50. PubMed ID: 11139597
[TBL] [Abstract][Full Text] [Related]
18. Integration of micronucleus tests with a gene mutation assay in F344 gpt delta transgenic rats using benzo[a]pyrene.
Hori H; Shimoyoshi S; Tanaka Y; Momonami A; Masumura K; Yamada M; Fujii W; Kitagawa Y
Mutat Res Genet Toxicol Environ Mutagen; 2019 Jan; 837():1-7. PubMed ID: 30595204
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of the E. coli K-12 uvrB/recA DNA repair host-mediated assay. II. In vivo results for 36 compounds tested in the mouse.
Hellmér L; Bolcsfoldi G
Mutat Res; 1992 Oct; 272(2):161-73. PubMed ID: 1383748
[TBL] [Abstract][Full Text] [Related]
20. Quantifying in vivo somatic mutations using transgenic mouse model systems.
Swiger RR
Methods Mol Biol; 2014; 1105():271-82. PubMed ID: 24623235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
